Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $89.99 | 1 | 50.7% |
| Food and Beverage | $87.56 | 5 | 49.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $89.99 | 1 | $0 (2018) |
| Sirtex Medical Inc | $87.56 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $26.75 | 1 | Sirtex Medical Inc ($26.75) |
| 2023 | $48.83 | 3 | Sirtex Medical Inc ($48.83) |
| 2018 | $101.97 | 2 | Astellas Pharma US Inc ($89.99) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/09/2024 | Sirtex Medical Inc | SIR-Spheres Microspheres (Device) | Food and Beverage | Cash or cash equivalent | $26.75 | General |
| Category: Interventional Oncology | ||||||
| 10/10/2023 | Sirtex Medical Inc | SIR-Spheres Microspheres (Device) | Food and Beverage | Cash or cash equivalent | $25.17 | General |
| Category: Interventional Oncology | ||||||
| 08/22/2023 | Sirtex Medical Inc | SIR-Spheres Microspheres (Device) | Food and Beverage | Cash or cash equivalent | $2.75 | General |
| Category: Interventional Oncology | ||||||
| 05/02/2023 | Sirtex Medical Inc | SIR-Spheres Microspheres (Device) | Food and Beverage | Cash or cash equivalent | $20.91 | General |
| Category: Interventional Oncology | ||||||
| 07/16/2018 | Astellas Pharma US Inc | — | Education | In-kind items and services | $89.99 | General |
| 06/06/2018 | Sirtex Medical Inc | SIR-Spheres Microspheres (Device) | Food and Beverage | Cash or cash equivalent | $11.98 | General |
| Category: Interventional Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,502 | 2,223 | $616,484 | $135,113 |
| 2022 | 18 | 1,611 | 2,377 | $667,645 | $155,185 |
| 2021 | 19 | 1,717 | 2,493 | $693,295 | $180,143 |
| 2020 | 18 | 2,074 | 3,222 | $936,903 | $247,488 |
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 177 | 180 | $258,476 | $60,086 | 23.2% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 169 | 688 | $110,768 | $29,492 | 26.6% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 173 | 352 | $128,480 | $15,045 | 11.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 228 | 228 | $46,284 | $12,996 | 28.1% |
| 93017 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) | Office | 2023 | 172 | 175 | $20,825 | $3,668 | 17.6% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 172 | 175 | $11,725 | $2,916 | 24.9% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 172 | 175 | $7,700 | $1,929 | 25.0% |
| 79005 | Radioactive drug therapy by mouth | Facility | 2023 | 21 | 21 | $4,746 | $1,211 | 25.5% |
| 78580 | Nuclear medicine study of lung circulation | Facility | 2023 | 41 | 44 | $4,092 | $1,176 | 28.8% |
| 78830 | Nuclear medicine study, spect imaging with concurrent ct scan, 1 area or single acquisition, single day imaging | Facility | 2023 | 18 | 22 | $4,070 | $1,143 | 28.1% |
| 78608 | Nuclear medicine study of brain with metabolic evaluation | Office | 2023 | 21 | 21 | $3,675 | $1,107 | 30.1% |
| 78018 | Nuclear medicine study of whole body for thyroid cancer | Facility | 2023 | 31 | 33 | $3,498 | $1,005 | 28.7% |
| 78803 | Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | Facility | 2023 | 25 | 25 | $3,375 | $958.65 | 28.4% |
| 78306 | Nuclear medicine study of bone and/or joint whole body | Facility | 2023 | 28 | 30 | $3,300 | $899.97 | 27.3% |
| 78264 | Nuclear medicine study of stomach to assess emptying | Facility | 2023 | 20 | 20 | $2,000 | $526.14 | 26.3% |
| 78227 | Nuclear medicine study of liver and bile duct system with use of drugs | Facility | 2023 | 12 | 12 | $1,380 | $365.64 | 26.5% |
| 78802 | Nuclear medicine study, whole body | Facility | 2023 | 11 | 11 | $1,089 | $320.19 | 29.4% |
| 78597 | Nuclear medicine study of lung ventilation and blood flow to lung | Facility | 2023 | 11 | 11 | $1,001 | $268.60 | 26.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 188 | 190 | $276,899 | $66,928 | 24.2% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2022 | 180 | 728 | $117,208 | $35,390 | 30.2% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2022 | 187 | 378 | $137,970 | $16,784 | 12.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2022 | 222 | 222 | $45,066 | $13,004 | 28.9% |
| 93017 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) | Office | 2022 | 186 | 188 | $22,372 | $3,884 | 17.4% |
| 78814 | Nuclear medicine study limited area with ct scan | Office | 2022 | 45 | 45 | $12,156 | $3,657 | 30.1% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2022 | 186 | 188 | $12,596 | $3,248 | 25.8% |
About Dr. Gamal Sidarous, MD
Dr. Gamal Sidarous, MD is a Nuclear Medicine healthcare provider based in Phoenix, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699731802.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gamal Sidarous, MD has received a total of $177.55 in payments from pharmaceutical and medical device companies, with $26.75 received in 2024. These payments were reported across 6 transactions from 2 companies. The most common payment nature is "Education" ($89.99).
As a Medicare-enrolled provider, Sidarous has provided services to 6,904 Medicare beneficiaries, totaling 10,315 services with total Medicare billing of $717,930. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Practice Information
- Specialty Nuclear Medicine
- Location Phoenix, AZ
- Active Since 04/25/2006
- Last Updated 05/19/2008
- Taxonomy Code 207U00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1699731802
Products in Payments
- SIR-Spheres Microspheres (Device) $87.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nuclear Medicine Doctors in Phoenix
Dr. Steve Huang, M.d./Ph.d, M.D./PH.D
Nuclear Medicine — Payments: $237.10
Mrs. Nancy Youssef, Md, MD
Nuclear Medicine — Payments: $112.74
Michael Lawson, M.d, M.D
Nuclear Medicine — Payments: $20.07
Dr. Frank Schraml, M.d, M.D
Nuclear Medicine
Calvin Lutrin, Md, MD
Nuclear Medicine
Howard Baxter, Md, MD
Nuclear Medicine